Mostrando 3 resultados de: 3
Filtros aplicados
Origen
scopus(3)
Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels
ArticleAbstract: Prostate cancer (PC) is the main cause of cancer mortality in men worldwide. Therefore, novel treatmPalabras claves:Anti-histamine, Astemizole, Eag1, ion channels, Prostate cancerAutores:Bernal-Ramos G., Chávez-lópez M.d.G., Garrido E., Hernández-gallegos E., Javier Camacho, Sánchez-Pérez Y., Vera E., Zúñiga-García V.Fuentes:scopusAstemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusEag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
ReviewAbstract: Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide. HCC is usually asymptomatPalabras claves:Astemizole, Diethylnitrosamine, Eag1, hepatocellular carcinoma, ion channelsAutores:Avalos-fuentes A., de Guadalupe Chávez-López M., Escobar Y., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopus